Literature DB >> 10805340

Increased serum transferrin receptor concentrations in Friedreich ataxia.

R B Wilson1, D R Lynch, J M Farmer, D G Brooks, K H Fischbeck.   

Abstract

Mitochondrial iron accumulation is thought to underlie the pathophysiology of Friedreich ataxia and may occur at the expense of cytosolic iron. Decreases in cytosolic iron induce expression of the transferrin receptor, some of which is released into the serum. Here, we demonstrate that serum transferrin receptor concentrations are increased in patients with Friedreich ataxia, which supports the hypothesis that it is a disease of abnormal intracellular iron distribution.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805340

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

Review 1.  Friedreich ataxia: from GAA triplet-repeat expansion to frataxin deficiency.

Authors:  P I Patel; G Isaya
Journal:  Am J Hum Genet       Date:  2001-06-04       Impact factor: 11.025

2.  Iron in neurodegenerative disorders.

Authors:  D. Berg; G. Becker; P. Riederer; O. Riess
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

Review 3.  Friedreich ataxia: molecular mechanisms, redox considerations, and therapeutic opportunities.

Authors:  Renata Santos; Sophie Lefevre; Dominika Sliwa; Alexandra Seguin; Jean-Michel Camadro; Emmanuel Lesuisse
Journal:  Antioxid Redox Signal       Date:  2010-09-01       Impact factor: 8.401

4.  Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design.

Authors:  Lisa S Friedman; Jennifer M Farmer; Susan Perlman; George Wilmot; Christopher M Gomez; Khalaf O Bushara; Katherine D Mathews; S H Subramony; Tetsuo Ashizawa; Laura J Balcer; Robert B Wilson; David R Lynch
Journal:  Mov Disord       Date:  2010-03-15       Impact factor: 10.338

Review 5.  Autosomal recessive cerebellar ataxias.

Authors:  Francesc Palau; Carmen Espinós
Journal:  Orphanet J Rare Dis       Date:  2006-11-17       Impact factor: 4.123

Review 6.  Role of frataxin protein deficiency and metabolic dysfunction in Friedreich ataxia, an autosomal recessive mitochondrial disease.

Authors:  Elisia Clark; Joseph Johnson; Yi Na Dong; Elizabeth Mercado-Ayon; Nathan Warren; Mattieu Zhai; Emily McMillan; Amy Salovin; Hong Lin; David R Lynch
Journal:  Neuronal Signal       Date:  2018-11-02

7.  Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia.

Authors:  David R Lynch; Jennifer Farmer; Lauren Hauser; Ian A Blair; Qing Qing Wang; Clementina Mesaros; Nathaniel Snyder; Sylvia Boesch; Melanie Chin; Martin B Delatycki; Paola Giunti; Angela Goldsberry; Chad Hoyle; Michael G McBride; Wolfgang Nachbauer; Megan O'Grady; Susan Perlman; S H Subramony; George R Wilmot; Theresa Zesiewicz; Colin Meyer
Journal:  Ann Clin Transl Neurol       Date:  2018-11-10       Impact factor: 4.511

8.  Quantitative Proteomic and Network Analysis of Differentially Expressed Proteins in PBMC of Friedreich's Ataxia (FRDA) Patients.

Authors:  Deepti Pathak; Achal Kumar Srivastava; M V Padma; Sheffali Gulati; Moganty R Rajeswari
Journal:  Front Neurosci       Date:  2019-10-14       Impact factor: 4.677

Review 9.  Molecular Defects in Friedreich's Ataxia: Convergence of Oxidative Stress and Cytoskeletal Abnormalities.

Authors:  Frances M Smith; Daniel J Kosman
Journal:  Front Mol Biosci       Date:  2020-11-09

Review 10.  An Overview of the Ferroptosis Hallmarks in Friedreich's Ataxia.

Authors:  Riccardo Turchi; Raffaella Faraonio; Daniele Lettieri-Barbato; Katia Aquilano
Journal:  Biomolecules       Date:  2020-10-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.